financetom
Business
financetom
/
Business
/
J&J plans to invest more than $55 billion in US over next four years
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
J&J plans to invest more than $55 billion in US over next four years
Mar 21, 2025 3:20 AM

(Reuters) -Johnson & Johnson said on Friday it plans to invest more than $55 billion over the next four years to build manufacturing facilities and research infrastructure in the United States.

The drug and device maker said this represents an increase of 25% in investment compared to the past four years.

The company plans to build three new manufacturing facilities in the U.S., in addition to a site in Wilson, North Carolina, on which it officially broke ground on Friday.

It also plans to expand several of its existing sites in the country, which already houses more production facilities than other countries, J&J said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Brazil's Vale buys out Baoshan's stake in Baovale, report says
Brazil's Vale buys out Baoshan's stake in Baovale, report says
Feb 6, 2025
SAO PAULO, Feb 6 (Reuters) - Brazilian miner Vale has agreed to buy a 50% stake in Baovale from its Chinese partner Baoshan Iron & Steel, taking control of the company, newspaper Valor Economico reported on Thursday. ...
Jeffs' Brands Enters Into Definitive Agreement to Complete Fort Products-Impact Acquisitions Merger
Jeffs' Brands Enters Into Definitive Agreement to Complete Fort Products-Impact Acquisitions Merger
Feb 6, 2025
10:59 AM EST, 02/06/2025 (MT Newswires) -- Jeffs' Brands ( JFBR ) said Thursday it has entered into a definitive agreement to complete the planned merger of its Fort Products unit with Impact Acquisitions. Under the terms of the deal, Impact will acquire 100% of Fort Products' equity interests from Jeffs' Brands ( JFBR ). The company will receive between...
Dr. Reddy's Laboratories Has Licensing Deal for Potential Multiple Myeloma Treatment
Dr. Reddy's Laboratories Has Licensing Deal for Potential Multiple Myeloma Treatment
Feb 6, 2025
10:57 AM EST, 02/06/2025 (MT Newswires) -- Dr. Reddy's Laboratories (RDY) said Thursday it has a licensing agreement with Shanghai Henlius Biotech for HLX15, an investigational daratumumab biosimilar to treat multiple myeloma. The agreement grants Dr. Reddy's exclusive commercialization rights for both subcutaneous and intravenous formulations of HLX15 in the US and Europe, the company said. Henlius will manage development,...
Revance Therapeutics Acquired by Crown Laboratories
Revance Therapeutics Acquired by Crown Laboratories
Feb 6, 2025
10:52 AM EST, 02/06/2025 (MT Newswires) -- Revance Therapeutics ( RVNC ) has been acquired by privately held Crown Laboratories, Crown said Thursday. Crown said its tender offer to acquire all of Revance's outstanding shares at $3.65 per share expired a minute past 11:59 pm ET on Tuesday and wasn't further extended. The company said Revance's common shares will be...
Copyright 2023-2026 - www.financetom.com All Rights Reserved